MYOSIN THERAPEUTICS INC.: Phase 0/I dose escalation trial of MT-125 monotherapy in recurrent high-grade gliomas
MYOSIN THERAPEUTICS INC. (Jupiter, Florida): Phase 0/I dose escalation trial of MT-125 monotherapy in recurrent high-grade gliomas. Its award of $2,241,448 is top-decile (96th percentile of 10,712 records). Dated 48 days ago, it serves as a historical benchmark. Score 70/100. As of 2026-11-03, from NIH RePORTER (newly awarded projects).
Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)
award: $2,241,448 · 96th percentile of 10,712 NihBiotechGrantPulse records · 5.5x the median
Free preview: all 10 published fields of this record are shown below. Locked: 314 related FL NihBiotechGrantPulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Organization | MYOSIN THERAPEUTICS INC. |
| Location | JUPITER, FL |
| Project | Phase 0/I dose escalation trial of MT-125 monotherapy in recurrent high-grade gliomas |
| Project number | 5R44CA278293-05 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $2,241,448 |
| Awarded | 2026-09-17 |
| Project period | 2023-04-01 to 2027-07-31 |
| UEI | MLH1HUK133H3 |
| award percentile | 96th of 10,712 (median $407,048, 5.5x median) |
| Peer records CSV (315 FL records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch MYOSIN THERAPEUTICS INC.
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock MYOSIN THERAPEUTICS + all 315 FL records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Organization · State · Institute · Award · Awarded · official source URL
- Source agency: NIH RePORTER (newly awarded projects)
- Record date: 2026-09-17
- Data refreshed: 2026-11-03
- Refunds on request within 14 days
Top NihBiotechGrantPulse records (FL first): UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · UNIVERSITY OF FLORIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · UNIVERSITY OF FLORIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · Browse all by state and category →
LIVE PUBLIC DATA Source: NIH RePORTER (newly awarded projects) · Last refreshed: Tue, 03 Nov 2026 18:16:24 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: MYOSIN THERAPEUTICS INC. and 315 Florida peers
- Florida NihBiotechGrantPulse records like this one: 315
- MYOSIN THERAPEUTICS INC.'s award: 96th percentile of 10,712 records
- Timing: Low: older than 30 days
- Estimated pipeline if you contact every Florida peer: $63,000 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
70 / 100 Lab Budget Score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.
What is the NihBiotechGrantPulse record for MYOSIN THERAPEUTICS INC. in Jupiter, Florida?
MYOSIN THERAPEUTICS INC. received an NIH award of $2,241,448 on 2026-09-17: Phase 0/I dose escalation trial of MT-125 monotherapy in recurrent high-grade gliomas.
How does MYOSIN THERAPEUTICS INC. compare to other Florida NihBiotechGrantPulse records?
This is a top-decile record: its award of $2,241,448 is 5.5x the median of $407,048 across 10,712 records. It is 48 days old; check the official source for later updates before acting. Its Lab Budget Score of 70/100 puts it among the stronger signals in this feed.
MYOSIN THERAPEUTICS INC. vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date | Compare |
|---|---|---|---|---|---|
| MYOSIN THERAPEUTICS INC. | JUPITER, FL | 2,241,448 | 96th | 2026-09-17 | This record |
| UNIVERSITY OF MIAMI SCHOOL OF MEDICINE | CORAL GABLES, FL | 2,301,203 | 97th | 2026-09-10 | Compare MYOSIN THERAPEUTICS INC. vs UNIVERSITY OF MIAMI SCHOOL OF MEDICINE → |
| UNIVERSITY OF FLORIDA | GAINESVILLE, FL | 2,141,888 | 96th | 2026-09-08 | Compare MYOSIN THERAPEUTICS INC. vs UNIVERSITY OF FLORIDA → |
| UNIVERSITY OF MIAMI SCHOOL OF MEDICINE | CORAL GABLES, FL | 1,819,495 | 94th | 2026-09-17 | View record → |
Related records
- UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
- UNIVERSITY OF FLORIDA
- IONCOLOGI INC
- I-FUNCTION, INC.
- VIGILANT LABORATORIES LLC
- BOLD TYPE LLC
- H. LEE MOFFITT CANCER CTR & RES INST
- UNIVERSITY OF FLORIDA
- UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
- UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
- UNIVERSITY OF FLORIDA
- UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
NihBiotechGrantPulse: records in Florida NihBiotechGrantPulse: Small business SBIR/STTR (R41-R44, U43-U44)
More Florida public-record feeds
New FDA Medical Device Listings by Manufacturer, CMO & Sterilizer in Florida New, Terminating & Large 401(k) Plans from Form 5500 Filings in Florida School & Library E-Rate Contracts Up for Rebid in Florida SEC 8-K Corporate Trigger Events in Florida Credit Union Quarterly Changes, Mergers & New Charters (NCUA Call Reports) in Florida New MSHA Citations at Mines & Quarries by State in Florida HIPAA Breach Reports (500+ Individuals) by State & Type in Florida FEMA Hazard Mitigation Project Tracker in Florida
How to monitor MYOSIN THERAPEUTICS INC. and peer small business sbir/sttr (r41-r44, u43-u44) records
Get new NihBiotechGrantPulse records like MYOSIN THERAPEUTICS INC. by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get newly funded labs in your territory
NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.